CRAIC Technologies new flagship product is designed to non-destructively analyze many types of microscopic samples from the deep ultraviolet to the near infrared. Analysis of samples can be done by absorbance, reflectance, luminescence and fluorescence with unparalleled speed and accuracy.
Applied Nanotech Holdings, Inc. announced that it will showcase some of its key nanotechnology advancements at nano tech 2010 held February 17-19 in Tokyo, Japan at Tokyo Big Site. ANI will highlight its printed electronics, sensor technology, and composites.
Applied Materials, Inc. announced today that Joe Flanagan has joined the company as senior vice president of Worldwide Operations and Supply Chain, responsible for developing and executing an integrated supply chain strategy that enhances enterprise value.
Oxford Instruments Plasma Technology (OIPT) is pleased to announce improved end-pointing capability on its range of plasma etch and deposition tools, with the introduction of the CCD1 Spectrometer system.
Seattle-based Modumetal has received a contract award from NAVAIR for an advanced nanolaminated coating that is expected to replace vapor-deposited cadmium in a high temperature, high impact environment.
The new hub, which includes equipment and infrastructure acquired from NXP Semiconductors' facility in Caen, offers comprehensive failure analysis and reliability testing for semiconductor companies in Europe and Israel.
Agilent Technologies Inc. announced the appointments of Robert Schueren as vice president and general manager, Genomics; and John Fjeldsted, Ph.D., as general manager, Liquid Chromatography/Mass Spectrometry.
Mitsubishi Electric Corporation announced today it has set two world records for photoelectric conversion efficiency in polycrystalline silicon photovoltaic (PV) cells, achieved by reducing resistive loss in the cells.
Malvern Instruments will focus on its range of analytical instrumentation for life science applications, with an emphasis on the company's comprehensive solutions for characterizing proteins and other macromolecules.
Park Systems' XE-Bio helped researchers at Stanford University discover a vulnerable step in the virus' reproduction process that in lab testing could be effectively targeted with an obsolete antihistamine.